New Beginnings24 Jan 2024 09:42
I think we all have to accept that what CG had hoped to achieve has failed. The whole CBD sector has taken a hammering both in the US and the UK, with most companies having gone bust or been sold for peanuts. So what next for CG? The management are hedging their bets as to what might be the next big thing - Carbon Credits, AI and to be fair none of us have any real idea what that could be. I have always been a believer that Cannabinoids will have a future and that synthetic cannabinoids is the way to go, so I'd plead with the powers that be to look at developing the core synthetic cannabinoids, which will be the pharma of the future. CG doesn't have to make the end products, just supply the raw ingredient - so not cash intensive and no large marketing spend.